G, P., D, M., & CM, D. (2025). Acceptance of Evidence Transfer Within German Early Benefit Assessment of New Drugs for Pediatric and Adolescents Target Populations. PharmacoEconomics, 43(5), 521. https://doi.org/10.1007/s40273-024-01467-8
Chicago Style (17th ed.) CitationG, Pick, Müller D, and Dintsios CM. "Acceptance of Evidence Transfer Within German Early Benefit Assessment of New Drugs for Pediatric and Adolescents Target Populations." PharmacoEconomics 43, no. 5 (2025): 521. https://doi.org/10.1007/s40273-024-01467-8.
MLA (9th ed.) CitationG, Pick, et al. "Acceptance of Evidence Transfer Within German Early Benefit Assessment of New Drugs for Pediatric and Adolescents Target Populations." PharmacoEconomics, vol. 43, no. 5, 2025, p. 521, https://doi.org/10.1007/s40273-024-01467-8.